Literatura académica sobre el tema "Amanitine"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Amanitine".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Amanitine"
Kubicka, Magdalena, Joanna Wilk, Paweł Dębiec, Krystian Cholewa, Magdalena Makarewicz y Adrianna Szymańska. "Amanitine poisoning - cases, management, therapy results". Journal of Education, Health and Sport 13, n.º 4 (1 de marzo de 2023): 276–80. http://dx.doi.org/10.12775/jehs.2023.13.04.032.
Texto completoMydlík, M. "Haemoperfusion of Alfa Amanitine -- In Vitro Study". Toxicology Letters 78 (agosto de 1995): 59. http://dx.doi.org/10.1016/03784-2749(59)4855b-.
Texto completoGicquel, T., S. Lepage, O. Tribut, B. Duretz y I. Morel. "O44: Dosage des amatoxines (α-amanitine, β-amanitine) et de la phalloidine dans les urines par LC-HR-MS". Toxicologie Analytique et Clinique 26, n.º 2 (junio de 2014): S25—S26. http://dx.doi.org/10.1016/s2352-0078(14)70052-6.
Texto completoVlaskin, D. N., E. T. Gainullina, O. V. Klyuster, I. V. Rybal’chenko, S. B. Ryzhikov y V. F. Taranchenko. "Express method for detection of Amanita phalloides amanitine toxins". Bulletin of Experimental Biology and Medicine 141, n.º 1 (enero de 2006): 110–11. http://dx.doi.org/10.1007/s10517-006-0107-2.
Texto completoSchenk, M., S. Rubitschek, C. Thiel, K. Knubben, M. M. Morgalla, A. Etspüler y A. Königsrainer. "AMANITINE INTOXICATION IN A PORCINE MODEL: WHEN TRANSPLANT, WHEN WAIT FOR REGENERATION?" Transplantation 86, Supplement (julio de 2008): 198. http://dx.doi.org/10.1097/01.tp.0000332246.68047.7d.
Texto completoMuraoka, Shinjiro, Nobuko Fukamachi, Kiyohisa Mizumoto y Takao Shinozawa. "Detection and Identification of Amanitins in the Wood-Rotting Fungi Galerina fasciculata andGalerina helvoliceps". Applied and Environmental Microbiology 65, n.º 9 (1 de septiembre de 1999): 4207–10. http://dx.doi.org/10.1128/aem.65.9.4207-4210.1999.
Texto completoFeigel, Bartłomiej, ariusz Zuba y Wojciech Lechowicz. "Screening method for the analysis of blood and urine for the presence of naturally occurring toxic compounds from mushrooms (fungi) using the LC-MS method". Problems of Forensic Sciences, n.º 126-127 (29 de marzo de 2022): 137–51. http://dx.doi.org/10.4467/12307483pfs.20.008.15448.
Texto completoFlammer, René y Katharina M. Schenk-Jäger. "Pilzvergiftungen – die Schattenseiten des Myzetismus". Therapeutische Umschau 66, n.º 5 (1 de mayo de 2009): 357–64. http://dx.doi.org/10.1024/0040-5930.66.5.357.
Texto completoRėkutė, Skirmantė, Marius Miglinas y Laurynas Rimševičius. "DAŽNIAUSI APSINUODIJIMO GRYBAIS SINDROMAI IR INKSTŲ PAŽEIDIMAI". Medicinos teorija ir praktika 22, n.º 3 (2 de enero de 2017): 213–17. http://dx.doi.org/10.15591/mtp.2016.033.
Texto completoBever, Candace S., Kenneth D. Swanson, Elizabeth I. Hamelin, Michael Filigenzi, Robert H. Poppenga, Jennifer Kaae, Luisa W. Cheng y Larry H. Stanker. "Rapid, Sensitive, and Accurate Point-of-Care Detection of Lethal Amatoxins in Urine". Toxins 12, n.º 2 (15 de febrero de 2020): 123. http://dx.doi.org/10.3390/toxins12020123.
Texto completoTesis sobre el tema "Amanitine"
Le, Daré Brendan. "Xénobiotiques hépatotoxiques : études de métabolisme et mécanismes d’action". Thesis, Rennes 1, 2021. http://www.theses.fr/2021REN1B005.
Texto completoXenobiotic-induced hepatotoxicity is an extremely rich subject, given the multiple mechanisms and actors involved. This translational work aims to improve ethanol and amanitins (powerful fungal toxins) hepatotoxic mechanisms understanding, in order to provide new elements to optimize the therapeutic management of intoxicated patients. In a first step, we provide additional elements of understanding on macrophages response mechanisms to ethanol. These xenobiotic-cell interactions, shown through the P2X7 receptor induction example, seem to contribute in alcoholic liver damage severity, and testify to the macrophages plasticity in pathological situations. These results suggest in particular the interest of P2X7 receptor antagonist’s development in the treatment of alcoholism. In a second step, we are applied molecular networking, which allows the visualization of complex data acquired by LC-MS/MS, to xenobiotic metabolism study. The acebutolol metabolism example, in the context of voluntary drug intoxication on the one hand, and the in vitro quetiapine metabolism study on the other hand, have provided consistent evidence concerning molecular network interest in this context. In a third and final step, the molecular network application allowed us to rule out the hypothesis of an in vivo and in vitro amanitins metabolism. Moreover, our results show that the hepatocyte-like cellular model of differentiated HepaRG is a relevant model in amanitins study, and show the mitochondrial ROS production implication in these substances toxicity
Nakaya, Helder Takashi Imoto. "Identificação e análise de expressão de RNAs intrônicos não codificadores humanos". Universidade de São Paulo, 2007. http://www.teses.usp.br/teses/disponiveis/46/46131/tde-08052007-144816/.
Texto completoIn this work, we show large-scale studies of antisense noncoding RNAs transcribed from intronic regions of human genes. The correlation of expression levels of some intronic transcripts to the degree of tumor differentiation in prostate cancer points to the biological relevance of these messages in complex diseases such as cancer. We also evaluated the existence of a common mechanism of regulation of transcription shared by protein-coding mRNAs and intronic RNAs by measuring the effect of androgen on the transcriptional profile of a prostate cancer cell line. Survey of mRNA and EST public databases revealed more than 55,000 Totally Intronic Noncoding (TIN) RNAs transcribed from the introns of 74% of all unique RefSeq genes. Guided by this information, we designed an oligoarray platform containing sense and antisense probes for each of 7,520 randomly-selected TIN transcripts plus probes for the corresponding protein-coding genes. We identified exonic and intronic tissue-specific expression signatures for human liver, prostate and kidney. The most highly expressed antisense TIN RNAs were transcribed from introns of proteincoding genes enriched in the \"Regulation of transcription\" class. RNA Polymerase II inhibition resulted in increased expression of a fraction of the intronic RNAs in cell cultures, suggesting that other RNA polymerases may be involved in their biosynthesis. A subset of intronic and protein-coding signatures transcribed from the same genomic loci has correlated expression patterns, suggesting that intronic RNAs regulate the abundance or the pattern of exon usage in protein-coding messages. We have identified diverse intronic RNA expression patterns, indicating that they may have regulatory roles. This gene-oriented approach, using a combined intronic/exonic microarray should permit further comparative analysis of intronic transcription under various physiological and pathological conditions, thus advancing current knowledge about the biological functions of these noncoding RNAs.
Amaral, Paulo de Paiva Rosa. "Estudo da biossíntese e regulação de RNAs não-codificadores intrônicos em células humanas". Universidade de São Paulo, 2006. http://www.teses.usp.br/teses/disponiveis/46/46131/tde-03012007-000256/.
Texto completoIt has been recently shown that the bulk of the transcription in human cells is comprised of non-protein-coding RNAs (or noncoding RNAs - ncRNAs) transcribed from introns and intergenic regions of the genome. Previous work from our group has demonstrated that expression of long intronic ncRNAs can be correlated to the degree of prostate tumor differentiation, underscoring the physiological relevance of these transcripts. However, the properties, functions, and regulation of this huge population of ncRNAs remain largely unknown. The present work aimed to investigate the biosynthesis of intronic ncRNAs and aspects of its regulation in human cells, focusing on the contribution of RNA Polymerase II (RNAP II). Initially, the model of regulation of gene expression by androgen hormone was used in order to evaluate the participation of the RNAP II transcription factor Androgen Receptor (AR) in the transcriptional regulation of intronic ncRNAs. Chromatin immunoprecipitation experiments revealed the binding of the AR in an androgen response element (ARE) present in a putative promoter driving the expression of an antisense intronic transcript in Myo5A locus in LNCaP cells. The interaction occurred in an androgen-inducible fashion, along with the up-regulation of the transcript, suggesting that hormone activation occurred in a direct manner mediated by the AR. In a different approach, the effect of RNAP II inhibition with α-amanitin for 24 h in LNCaP cells was analyzed using an oligoarray representing totally and partially intronic transcripts, as well as exons of proteincoding genes. The expression of less than 20 % of the intronic transcripts was affected by the treatment, contrasting to a significantly higher fraction observed for exonic messages (40 %). Moreover, most differentially expressed intronic transcripts were down-regulated, but strikingly 13 to 16 % were up-regulated in cells with blocked RNAP II, while this fraction for exonic transcripts was about 2 %. The results described here demonstrate that RNAP II in fact plays a role in intronic transcription in human cells, but also highlight that another transcriptional system may account for the biogenesis of a fraction of intronic ncRNAs.
Brückner, Florian. "Molecular basis of translocation, alpha-amanitin inhibition, and CPD damage recognition by RNA polymerase II". Diss., lmu, 2008. http://nbn-resolving.de/urn:nbn:de:bvb:19-86461.
Texto completoBrückner, Florian. "Molecular basis of translocation, alpha-amanitin inhibition, and CPD damage recognition by RNA polymerase II". kostenfrei, 2008. http://edoc.ub.uni-muenchen.de/8646/.
Texto completoCHAUD, JEAN-PAUL. "L'intoxication phalloidienne : a propos de quatre observations recensees dans le departement des alpes-maritimes". Nice, 1988. http://www.theses.fr/1988NICE6539.
Texto completoBENVENUTO, VINCENT. "Intoxication phalloidienne : aspect botanique, toxicologique, clinique, therapeutique et preventif". Saint-Etienne, 1989. http://www.theses.fr/1989STET6215.
Texto completoDietrich, David John. "Synthesis and evaluation of probes of RNA polymerase II : adaptation of the bicyclic scaffold of the octapeptide amanitin". Thesis, University of British Columbia, 2010. http://hdl.handle.net/2429/27427.
Texto completoKorsak, Barbara [Verfasser]. "DUPA α-Amanitin Conjugates for Targeted Prostate Cancer Therapy - Optimization and Evaluation of In Vivo Potency / Barbara Korsak". Bielefeld : Universitätsbibliothek Bielefeld, 2021. http://d-nb.info/1237815606/34.
Texto completoSEITZ, ISABELLE. "Pharmacologie et toxicologie de l'amanite tue-mouche : ses aspects historiques et modernes". Strasbourg 1, 1991. http://www.theses.fr/1991STR15023.
Texto completoLibros sobre el tema "Amanitine"
Mullersman, Jerald Eric. Chemical modification of alpha-amanitin to yield derivatives suitable for conjugation to proteins via reductive alkylation. 1986.
Buscar texto completoTamin, Azaibi. Molecular genetic analysis of vaccinia virus genes which confer resistance to alpha-amanitin. 1989.
Buscar texto completoCapítulos de libros sobre el tema "Amanitine"
Vidal, C. y W. R. Külpmann. "Amanitine". En Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_159-1.
Texto completoVidal, C. y W. R. Külpmann. "Amanitine". En Springer Reference Medizin, 83–84. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_159.
Texto completoFaulstich, Heinz y Theodor Wieland. "New Aspects of Amanitin and Phalloidin Poisoning". En Advances in Experimental Medicine and Biology, 309–14. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0361-9_24.
Texto completoFenoil, R., R. Alfieri y G. Weisz. "A Rapid and Sensitive HPLC Method for Determination of Alpha Amanitin in Urine". En Developments in Analytical Methods in Pharmaceutical, Biomedical, and Forensic Sciences, 143–46. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4899-3526-7_16.
Texto completo"Amanitin (C39H54N10O13S)". En Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 74. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_599.
Texto completo"Amanitin Toxicosis". En Clinical Veterinary Advisor, 21–22. Elsevier, 2012. http://dx.doi.org/10.1016/b978-1-4160-9979-6.00014-3.
Texto completo"A-I (Abscisic acid to Amanitins)". En RÖMPP Encyclopedia Natural Products, editado por Wolfgang Steglich, Burkhard Fugmann y Susanne Lang-Fugmann. Stuttgart: Georg Thieme Verlag, 2000. http://dx.doi.org/10.1055/b-0036-133798.
Texto completoArici, M. Aylin y Yesim Tuncok. "Mushroom-related toxins, alpha amanitin, and usage of antioxidants: Directions toward antioxidant capacity". En Toxicology, 447–56. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-819092-0.00044-3.
Texto completo"Raise of a Monoclonal Antibody Against et-Amanitin and Studies on its Molecular Interaction with Amatoxin Peptides". En Proceedings of the Fifth USSR-FRG Symposium on Chemistry of Peptides and Proteins, Odessa, USSR, May 16–20, 1985, 331–38. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110858846-031.
Texto completoActas de conferencias sobre el tema "Amanitine"
Kulke, Michael, Anikó Pálfi, Christoph Müller, Werner Simon, Susanne Werner-Simon, Christian Lutz, Torsten Hechler y Andreas Pahl. "Abstract 735: SAR of amanitin and optimization of linker-amanitin derivatives for solid tumors". En Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-735.
Texto completoHechler, Torsten, Aniko Palfi, Christoph Müller, Christian Lutz, Andreas Pahl y Michael Kulke. "Abstract 62: CD19 - a potential target for Amanitin-based ADCs". En Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-62.
Texto completoPalfi, Aniko, Torsten Hechler, Christoph Mueller, Andreas Pahl y Michael Kulke. "Abstract 2973: CD269 - A promising target for amanitin based ADCs". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2973.
Texto completoHechler, Torsten, Christoph Müller, Andreas Pahl y Jan Anderl. "Abstract 633: Amanitin-based ADCs with an improved therapeutic index". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-633.
Texto completoBai, Xueke, Peixi Jiang y Yuyou Wu. "Toxic Mechanisms of α-Amanitin and Its Potential to Fight Cancer". En The International Conference on Biomedical Engineering and Bioinformatics. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011378000003443.
Texto completoAnderl, Jan, Christoph Müller, Brigitte Heckl-Östreicher y Roland Wehr. "Abstract 3616: Highly potent antibody-amanitin conjugates cause tumor-selective apoptosis". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3616.
Texto completoHechler, Torsten, Michael Kulke, Christoph Mueller, Andreas Pahl y Jan Anderl. "Abstract 664: Amanitin-based antibody-drug conjugates targeting the prostate-specific membrane antigen". En Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-664.
Texto completoPálfi, Anikó, Christian Breunig, Torsten Hechler, Christoph Müller, Christian Lutz, Andreas Pahl y Michael Kulke. "Abstract 740: Preclinical evaluation of an anti-PSMA antibody-targeted amanitin conjugate (ATAC)". En Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-740.
Texto completoBraun, Alexandra, Aniko Palfi, Christoph Mueller, Torsten Hechler, Andreas Pahl y Michael Kulke. "Abstract 910: Amanitin-based ADCs targeting PSMA as novel therapeutic modality for prostate cancer therapy". En Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-910.
Texto completoVoss, Stephanie, Aniko Palfi, Christoph Mueller, Andreas Pahl, Torsten Hechler y Michael Kulke. "Abstract 915: Preclinical evaluation of anti-CD37 antibody-targeted amanitin conjugates (ATAC) in B-cell malignancies". En Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-915.
Texto completo